Literature DB >> 24291066

Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.

Elena Marzo1, Cristina Vilaplana2, Gustavo Tapia3, Jorge Diaz4, Vanessa Garcia5, Pere-Joan Cardona6.   

Abstract

Tuberculosis was studied using an experimental model based on the C3HeB/FeJ mouse strain, which mimics the liquefaction of caseous necrosis occurring during active disease in immunocompetent adults. Mice were intravenously infected with 2 × 10(4) Colony Forming Units of Mycobacterium tuberculosis and their histopathology, immune response, bacillary load, and survival were evaluated. The effects of the administration of drugs with anti-inflammatory activity were examined, and the C3H/HeN mouse strain was also included for comparative purposes. Massive intra-alveolar neutrophilic infiltration led to rapid granuloma growth and coalescence of lesions into superlesions. A central necrotic area appeared showing progressive cellular destruction, the alveoli cell walls being initially conserved (caseous necrosis) but finally destroyed (liquefactive necrosis). Increasing levels of pro-inflammatory mediators were detected in lungs. C3HeB/FeJ treated with anti-inflammatory drugs and C3H/HeN animals presented lower levels of pro-inflammatory mediators such as TNF-α, IL-17, IL-6 and CXCL5, a lower bacillary load, better histopathology, and increased survival compared with untreated C3HeB/FeJ. The observation of massive neutrophilic infiltration suggests that inflammation may be a key factor in progression towards active tuberculosis. On the basis of our findings, we consider that the C3HeB/FeJ mouse model would be useful for evaluating new therapeutic strategies against human tuberculosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Active tuberculosis; C3HeB/FeJ mice; Experimental murine model of tuberculosis; Kramnik mouse model; Liquefaction; Neutrophils

Mesh:

Substances:

Year:  2013        PMID: 24291066     DOI: 10.1016/j.tube.2013.09.004

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  60 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development.

Authors:  Nestani Tukvadze; Paula Cardona; Sergo Vashakidze; Natalia Shubladze; Zaza Avaliani; Cris Vilaplana; Pere-Joan Cardona
Journal:  Int J Mycobacteriol       Date:  2016-11-14

Review 3.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 4.  To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps.

Authors:  Sebastian Boeltz; Poorya Amini; Hans-Joachim Anders; Felipe Andrade; Rostyslav Bilyy; Simon Chatfield; Iwona Cichon; Danielle M Clancy; Jyaysi Desai; Tetiana Dumych; Nishant Dwivedi; Rachael Ann Gordon; Jonas Hahn; Andrés Hidalgo; Markus H Hoffmann; Mariana J Kaplan; Jason S Knight; Elzbieta Kolaczkowska; Paul Kubes; Moritz Leppkes; Angelo A Manfredi; Seamus J Martin; Christian Maueröder; Norma Maugeri; Ioannis Mitroulis; Luis E Munoz; Daigo Nakazawa; Indira Neeli; Victor Nizet; Elmar Pieterse; Marko Z Radic; Christiane Reinwald; Konstantinos Ritis; Patrizia Rovere-Querini; Michal Santocki; Christine Schauer; Georg Schett; Mark Jay Shlomchik; Hans-Uwe Simon; Panagiotis Skendros; Darko Stojkov; Peter Vandenabeele; Tom Vanden Berghe; Johan van der Vlag; Ljubomir Vitkov; Maren von Köckritz-Blickwede; Shida Yousefi; Alexander Zarbock; Martin Herrmann
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

5.  Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production.

Authors:  Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Madhuri Bhagavathula; Padmini Salgame
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

6.  Bacillary replication and macrophage necrosis are determinants of neutrophil recruitment in tuberculosis.

Authors:  Teresa Repasy; Nuria Martinez; Jinhee Lee; Kim West; Wenjun Li; Hardy Kornfeld
Journal:  Microbes Infect       Date:  2015-04-07       Impact factor: 2.700

Review 7.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

8.  Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.

Authors:  Si-Yang Li; Scott M Irwin; Paul J Converse; Khisi E Mdluli; Anne J Lenaerts; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration.

Authors:  Magaiver Andrade-Silva; Luana Barbosa Correa; André Luis Peixoto Candéa; Simone C Cavalher-Machado; Helene Santos Barbosa; Elaine Cruz Rosas; Maria G Henriques
Journal:  Inflamm Res       Date:  2016-07-05       Impact factor: 4.575

Review 10.  Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.

Authors:  Jansy P Sarathy; Véronique Dartois
Journal:  Clin Microbiol Rev       Date:  2020-04-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.